Randomized Behavioral Sleep Clinical Trial to Improve Outcomes in Children With Down Syndrome

Area of Science:

• Pediatric Psychology
• Sleep Medicine
• Developmental Disabilities

Background:

• Sleep disturbances are common in children with Down syndrome (DS).
• Behavioral interventions are a promising avenue for improving sleep in this population.
• Caregiver well-being is often impacted by child sleep problems.

Purpose of the Study:

• To evaluate a specialized behavioral sleep treatment for children with Down syndrome.
• To assess the treatment's impact on child sleep, behavior, and caregiver outcomes.
• To compare the specialized treatment against a treatment-as-usual (TAU) control group.

Main Methods:

• A randomized clinical trial involving 30 school-age children with Down syndrome.
• Intervention duration of 5-8 weeks with assessments at baseline, post-treatment, and 3-month follow-up.
• Utilized actigraphy and parent-report measures for objective and subjective data collection in a double-blinded design.

Main Results:

• Both the active treatment and TAU groups demonstrated improvements in child sleep (actigraphy and parent-report).
• Parent-reported child internalizing behaviors and parent sleep (actigraphy) also improved in both groups.
• No statistically significant differences were found between the specialized behavioral sleep treatment and the TAU group.

Conclusions:

• The specialized behavioral sleep treatment showed positive effects, but not superior to standard care plus supplementary sessions.
• Further research is needed to refine interventions for optimizing sleep and behavior in children with Down syndrome.
• Findings suggest that while specialized treatments are beneficial, their advantage over comprehensive TAU needs further investigation.